Trial intelligence / Profile preview

Ginkgo Biloba Extract for Endothelial Function in Diabetic CAD

NCT01038050Phase 4Unknown

Sponsor
Taipei Veterans General Hospital
Start
Oct 2009
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ginkgo biloba extract in type 2 diabetes mellitus (T2DM), coronary artery disease (CAD), sponsored by Taipei Veterans General Hospital. Status: unknown.

02

Drugs

ginkgo biloba extract
03

Conditions

type 2 diabetes mellitus (T2DM)coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01038050.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01038050.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call